rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
1998-2-10
|
pubmed:abstractText |
Retrospective and case-control studies show that hyperhomocysteinemia is an independent risk factor for atherosclerosis in patients with end-stage renal disease. We studied prospectively the association between total homocysteine and cardiovascular outcomes.
|
pubmed:grant |
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0009-7322
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
20
|
pubmed:volume |
97
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
138-41
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:9445164-Adult,
pubmed-meshheading:9445164-Aged,
pubmed-meshheading:9445164-Cardiovascular Diseases,
pubmed-meshheading:9445164-Cause of Death,
pubmed-meshheading:9445164-Disease-Free Survival,
pubmed-meshheading:9445164-Female,
pubmed-meshheading:9445164-Homocysteine,
pubmed-meshheading:9445164-Humans,
pubmed-meshheading:9445164-Kidney Failure, Chronic,
pubmed-meshheading:9445164-Male,
pubmed-meshheading:9445164-Middle Aged,
pubmed-meshheading:9445164-Prospective Studies,
pubmed-meshheading:9445164-Risk Factors
|
pubmed:year |
1998
|
pubmed:articleTitle |
Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease.
|
pubmed:affiliation |
Department of Internal Medicine, The Cleveland Clinic Foundation, Ohio 44195, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|